Particularly with the expected adoption boost as biosimilars enter the market towards the end of the decade, affordability barriers may begin to crumble, especially in lower-income regions where GLP-1 access currently remains limited
Dont get caught up in the numbers, if youre unsure, call us today and we can help
In clinical studies, liraglutide and semaglutide both led to an average 0.3-point drop in A1c in prediabetic participants (after 56 weeks for liraglutide 5 and 68 weeks for semaglutide 6 )a small but meaningful shift for people whose blood sugar is creeping upward toward the diabetes threshold
How does obesity affect kidney function
We wanted to conduct a meta-analysis to find an answer to this question. Adnan Ezici For the meta-analysis, researchers analyzed data from four studies with 396 participants with type 2 diabetes and/or obesity, comparing GLP-1 therapy (n = 199) to a control group of participants assigned placebo or other diabetes drugs (n = 197)